Table 7.

MPNST: a review of select recent single-institution retrospective series

Authors & Year	No. Patients	5 year survival	Adverse prognostic features					Therapy Benefit
			NF1	RAS	Location	Size	Positive Margins	RT	CT
Present series	289	52%a	T	NS	T (trunk)	S (≥ 10 cm)	S	NS	NS
LaFemina et al., 2013	105	-	NS	S	NS	S (larger)	S	-	-
Fan et al., 2013	146	57% b	NS	-	NS	NS	NS	NS	NS
Stucky et al., 2011	175	60% a	T	-	S (trunk)	S (≥ 5cm)	NS	NS	NS
Zou et al., 2009	140	39% a	NS	NS	NS	S (≥ 10 cm)	NS	NS	NS
Porter et al., 2008	123	51% b	S	-	NS	S (> 200 ml)	NS	NS	NS
Anghileri et al., 2006	205	40% a	NS	-	S (trunk, HN)	S (larger)	S	S	NS

Abbreviations: CT, chemotherapy; HN, head/neck; NF1, neurofibromatosis type1-associated MPNST; NS, not statistically significant; RAS, radiation-associated MPNST; RT, radiation therapy ; S, statistically significant; T, trend

^aDisease-specific survival

^bOverall survival

^cTri-site series for a single-institution